Addressing COVID-19 Among People Experiencing Homelessness: Description, Adaptation, and Early Findings of a Multiagency Response in Boston.

Public Health Reports
Travis P BaggettJessie M Gaeta

Abstract

People experiencing homelessness are at high risk for coronavirus disease 2019 (COVID-19). In March 2020, Boston Health Care for the Homeless Program, in partnership with city and state public health agencies, municipal leaders, and homeless service providers, developed and implemented a citywide COVID-19 care model for this vulnerable population. Components included symptom screening at shelter front doors, expedited testing at pop-up sites, isolation and management venues for symptomatic people under investigation and for people with confirmed disease, quarantine venues for asymptomatic exposed people, and contact investigation and tracing. Real-time disease surveillance efforts in a large shelter outbreak of COVID-19 during the third week of operations illustrated the need for several adaptations to the care model to better respond to the local epidemiology of illness among people experiencing homelessness. Symptom screening was de-emphasized given the high number of asymptomatic or minimally symptomatic infections discovered during mass testing; contact tracing and quarantining were phased out under the assumption of universal exposure among the sheltered population; and isolation and management venues were rapidly expanded...Continue Reading

References

May 12, 2004·Chest·Laurie D Snyder, Mark D Eisner
Jun 19, 2010·American Journal of Public Health·James J O'ConnellHoward K Koh
Jun 2, 2018·Journal of the American College of Cardiology·Travis P BaggettStephen W Hwang
Apr 28, 2020·JAMA : the Journal of the American Medical Association·Travis P BaggettJessie M Gaeta
May 1, 2020·MMWR. Morbidity and Mortality Weekly Report·Farrell A TobolowskyMeagan Kay
May 1, 2020·MMWR. Morbidity and Mortality Weekly Report·Emily MositesUNKNOWN COVID-19 Homelessness Team

❮ Previous
Next ❯

Citations

Sep 24, 2020·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Honora EnglanderCaroline King
Feb 9, 2021·The Lancet. Public Health·Travis P Baggett, Jessie M Gaeta
Feb 14, 2021·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Tran Duc Anh LyPhilippe Gautret
Feb 13, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Tran Duc Anh LyPhilippe Gautret
Nov 10, 2020·The International Journal on Drug Policy·Austin O'CarrollJohn Collins
Mar 19, 2021·American Journal of Public Health·Anahí Viladrich
Mar 30, 2021·The Lancet. Public Health·Chiedozie ArumUNKNOWN Homelessness, HIV, and HCV Review Collaborative Group
May 6, 2021·Public Health Reports·Andrey KuzmichevHazel D Dean
Jul 22, 2021·Journal of Travel Medicine·Victoria Y FanEdward Mersereau
Oct 8, 2021·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·Anthony Molloy, Page L Anderson
Oct 9, 2021·Public Health Nursing·Mary Lashley, K Daniel Stoltzfus
Dec 8, 2021·Harm Reduction Journal·Heidi BrociousLaVerne Xilegg Demientieff
Dec 30, 2021·Social Work in Public Health·Mohsen NouriAli Akbari Sari

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.